Efficacy of Dexmedetomidine in Preventing Contrast Induced Nephropathy

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

July 31, 2012

Conditions
Radiographic Contrast Agent Nephropathy
Interventions
DRUG

Dexmedetomidine

"Intravenously 1μg/kg/10min administered just before the procedure.~1 μg/kg/h administered during the angiography and was continued 1 hour after the angiography."

DRUG

0.9 % NaCl

During 12 hours before the procedure 3 ml/kg/h 0.9 % NaCl infusion and 1 ml/kg/h during the angioplasty and 12 hours after the procedure.

DRUG

0.9 % NaCl

"100 ml/10min infusion just before the angiography~1 ml/kg/h infusion during the angiography and was continued 12 hours after the procedure"

All Listed Sponsors
lead

TC Erciyes University

OTHER

NCT02137863 - Efficacy of Dexmedetomidine in Preventing Contrast Induced Nephropathy | Biotech Hunter | Biotech Hunter